Cell Sorter Market Expected to Reach $1.3 Billion by 2032—Allied Market Research

According to a new report published by Allied Market Research, titled, “Cell Sorter Market," The cell sorter market size was valued at $0.5 billion in 2022, and is estimated to reach $1.3 billion by 2032, growing at a CAGR of 8.6% from 2023 to 2032. Cell sorters have significant applications in medical diagnostics such as cancer diagnostics, immunology, and infectious disease research. They have the ability to isolate and analyze the specific cell types or biomarkers, which help in early detection, monitor disease progression, and develop targeted therapies.

The cell sorter market trends is driven by increase in prevalence of chronic and infectious diseases such as cancer requires advanced research tools for better understanding and treatment. This has led to an increase in demand for cell sorter devices that propels market growth. For instance, according to Globocan, an estimated 19.3 million new cancer cases occurred in 2020. Thus, the high prevalence of chronic and infectious diseases including cancer has led to an increased demand for cell sorter devices, which boosts market growth. These devices play a vital role in research aimed at understanding disease mechanisms, developing personalized treatments, discovering biomarkers, and advancing drug discovery.

In addition, the surge in focus on scientific research across various disciplines is a significant driving factor for the cell sorter market. Researchers in fields such as immunology, cancer biology, stem cell research, and genomics require cell sorting technologies to isolate specific cell populations for in-depth analysis and experimentation. The demand for cell sorters is fueled by the need to obtain homogeneous cell populations for various research, which further drive market growth.

Furthermore, emerging markets, particularly in regions such as Asia-Pacific and LAMEA present significant growth opportunities for the cell sorters market. These regions have witnessed rapid growth in healthcare infrastructure, increased research funding, and rise in awareness about advanced technologies.  

Moreover, companies continuously invest in research and development activities  to improve the efficiency, accuracy, and functionality of cell sorter instruments  which drives the growth of the market. For instance, one prominent company in the cell sorting market, Becton, Dickinson and Company offers the BD FACSAria Fusion cell sorter, which incorporates advanced technologies such as a digital acquisition system and enhanced detection capabilities, enabling high-speed sorting and analysis of cells.

In addition, Miltenyi Biotec offers cell sorters such as MACSQuant Tyto Cell Sorter (magnetic-activated cell sorting), a microchip-based sorting technology that is gentle and preserves cell viability and functionality with high-speed technology. These platforms enable researchers to identify and sort specific population of cancer cells for further analysis and experimentation. Such advanced features offered by cell sorters boost market growth.   

The cell sorter market size is segmented into product, application, end user, and region. On the basis of the product, the cell sorter industry is bifurcated into instruments and consumables and reagents. The instruments segment is further segmented into fluorescence-based droplet cell sorting, magnetic-activated cell sorting, and MEMS- Microfluidics. The instruments segment dominated market share in 2022 and is expected to register the highest CAGR during the forecast period owing to high adoption of fluorescence-based droplet cell sorting instruments as they are highly accurate and have precise sorting method.   

On the basis of application, the cell sorter industry is bifurcated into research applications and clinical applications. The research application segment is further segmented into immunology and cancer research, stem cell research, drug discovery, and other research applications. The research application segment accounted for the largest cell sorter market share in 2022 and is also expected to register the highest CAGR during the forecast period owing to increase in focus on research activities in immunology, cancer biology, and stem cell research which necessitates the use of cell sorting instruments to analyze mechanisms of cells These areas of study require the utilization of cell sorting processes, which contributes toward the cell sorters market growth.  

On the basis of end user, the cell sorter market analysis is categorized into hospitals and clinical testing laboratories, pharmaceutical and biotechnology companies, and others. The pharmaceutical and biotechnology companies segment occupied the largest share in 2022 owing to the availability of high-speed, high-throughput, and sophisticated cell sorting platforms allows these companies to process large volumes of cells quickly and accurately, enhancing their drug discovery and development processes. The hospitals and clinical testing laboratories segment is expected to register the highest CAGR during the cell sorter market forecast period, owing to rise in demand for advanced cell analysis techniques and growing burden of chronic diseases such as cancer in hospitals and clinics.  

Region wise, North America accounted for the largest share in 2022 owing to increase in cases of chronic diseases such as cancer, presence of major key players, government support, and funding for life sciences research and healthcare initiatives. In addition, well-developed healthcare infrastructure, such as advanced research facilities, strong presence of academic institutions, and pharmaceutical companies is expected to propel the market growth.   

This infrastructure supports the adoption of cell sorting technologies and encourages the use of advanced techniques for research and clinical applications, which is expected to drive the market growth in this region.  Furthermore, strategies such as acquisition and partnership adopted by key players further contribute toward the market growth in this region.   

For instance, in October 2020, On-chip Biotechnologies Co., Ltd. announced a new partnership with PHC Corporation of North America (PHCNA). PHCNA is anticipated to be distributing and marketing its products in North America. This partnership is expected to drive delivery of a platform for sterile, damage-free, and contamination-free sorting of cells for on-chip sort product.  

However, Asia-Pacific is anticipated to register the highest CAGR during the forecast period owing to a rise in research and development activities in fields such as biotechnology, pharmaceuticals, and life sciences and surge in healthcare expenditure. In addition, the rise in awareness and adoption of advanced technologies in various industries thereby drives the demand for cell sorters and propels the market growth in this region.

Key Findings of the Study

• On the basis of product, the instruments segment was largest contributor to the market in 2022.   
• On the basis of application, the research application segment was largest contributor to the market in 2022.   
• On the basis of end user, the pharmaceutical and biotechnology companies segment dominated the market in terms of revenue in 2022. However, hospitals and clinical testing laboratories segment is anticipated to grow at the highest CAGR during the forecast period. 
• Region wise, North America generated the largest revenue in 2022. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.